Hindsø, M. et al. 2021. Successful Use of a GLP-1 Receptor Agonist as Add-on Therapy to Sulfonylurea in the Treatment of KCNJ11 Neonatal Diabetes. European Journal of Case Reports in Internal Medicine. 8, 3 (Mar. 2021). DOI:https://doi.org/10.12890/2021_002352.